Cargando…

METTL3 suppresses anlotinib sensitivity by regulating m(6)A modification of FGFR3 in oral squamous cell carcinoma

BACKGROUND: N6-methyladenosine (m(6)A) is an abundant nucleotide modification in mRNA, but there were few studies on its role in cancer drug sensitivity and resistance. Anlotinib has been proved to have effective antitumor effects in oral squamous cell carcinoma (OSCC) in our previous study. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jie, Li, Shuai, Huang, Zhexun, Cao, Congyuan, Wang, Anxun, He, Qianting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516809/ https://www.ncbi.nlm.nih.gov/pubmed/36167542 http://dx.doi.org/10.1186/s12935-022-02715-7

Ejemplares similares

METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m(6)A Methylation in Oral Squamous Cell Carcinoma
por: Liu, Lin, et al.
Publicado: (2020)

Arecoline induces epithelial‐mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression
por: Ren, Hui, et al.
Publicado: (2021)

Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression
por: Chen, Jie, et al.
Publicado: (2022)

Alternative splicing of METTL3 explains apparently METTL3-independent m(6)A modifications in mRNA
por: Poh, Hui Xian, et al.
Publicado: (2022)

Mutational Status of FGFR3 in Oral Squamous Cell Carcinoma
por: Motahhary, P., et al.
Publicado: (2012)

METTL3-mediated m(6)A mRNA modification of FBXW7 suppresses lung adenocarcinoma
por: Wu, Yingtong, et al.
Publicado: (2021)

Case Report: Targeted Therapy with Anlotinib for a Rare Case of Spinal Cord Glioblastoma with FGFR3 Mutation
por: Liu, Ruiqiong, et al.
Publicado: (2022)

PLAA suppresses ovarian cancer metastasis via METTL3-mediated m(6)A modification of TRPC3 mRNA
por: Shen, Zhangjin, et al.
Publicado: (2022)

FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib
por: Hong, Chen, et al.
Publicado: (2022)

MCTS1 promotes invasion and metastasis of oral cancer by modifying the EMT process
por: Huang, Zhexun, et al.
Publicado: (2021)

Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway
por: Lu, Yunfei, et al.
Publicado: (2021)

METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m(6)A Modification
por: Zhao, Wei, et al.
Publicado: (2020)

Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation
por: Cao, Jian-zhou, et al.
Publicado: (2021)

METTL3-mediated m(6)A modification is required for cerebellar development
por: Wang, Chen-Xin, et al.
Publicado: (2018)

Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification
por: Liu, Yanyang, et al.
Publicado: (2021)

Pyruvate kinase M2 deregulation enhances the metastatic potential of tongue squamous cell carcinoma
por: Wang, Wei, et al.
Publicado: (2017)

Analysis of METTL3 and METTL14 in hepatocellular carcinoma
por: Liu, Xiangxiang, et al.
Publicado: (2020)

METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression
por: Guo, Yu-qing, et al.
Publicado: (2022)

METTL3-dependent m(6)A modification programs T follicular helper cell differentiation
por: Yao, Yingpeng, et al.
Publicado: (2021)

METTL3-Mediated m(6)A RNA Modification Regulates Corneal Injury Repair
por: Dai, Yarong, et al.
Publicado: (2021)

Mettl3-dependent m(6)A modification attenuates the brain stress response in Drosophila
por: Perlegos, Alexandra E., et al.
Publicado: (2022)

METTL3-mediated m(6)A modification stabilizes TERRA and maintains telomere stability
por: Chen, Liping, et al.
Publicado: (2022)

The Distinct Function and Localization of METTL3/METTL14 and METTL16 Enzymes in Cardiomyocytes
por: Arcidiacono, Orazio Angelo, et al.
Publicado: (2020)

Bmi1 Drives Stem-Like Properties and is Associated with Migration, Invasion, and Poor Prognosis in Tongue Squamous Cell Carcinoma
por: He, Qianting, et al.
Publicado: (2015)

N (6)-methyladenosine modification and METTL3 modulate enterovirus 71 replication
por: Hao, Haojie, et al.
Publicado: (2019)

DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m(6)A modification and translation for cytoprotective autophagy in cervical cancer
por: Zhu, Miaohua, et al.
Publicado: (2022)

METTL3 Is Involved in the Development of Graves’ Disease by Inducing SOCS mRNA m6A Modification
por: Song, Rong-hua, et al.
Publicado: (2021)

Drug-sensitive FGFR3 mutations in lung adenocarcinoma
por: Chandrani, P., et al.
Publicado: (2017)

Roles of the m6A methyltransferases METTL3, METTL14, and WTAP in pulmonary tuberculosis
por: Zhang, Tian-Ping, et al.
Publicado: (2022)

Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
por: Xu, Yeqiu, et al.
Publicado: (2023)

Mettl3-mediated m(6)A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration
por: Jiang, Fu-Qing, et al.
Publicado: (2022)

Methyltransferase METTL8 is required for 3-methylcytosine modification in human mitochondrial tRNAs
por: Lentini, Jenna M., et al.
Publicado: (2022)

METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS
por: Chen, Jie-Xun, et al.
Publicado: (2023)

METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing
por: Wang, Xiaotong, et al.
Publicado: (2023)

Solution structure of the RNA recognition domain of METTL3-METTL14 N(6)-methyladenosine methyltransferase
por: Huang, Jinbo, et al.
Publicado: (2018)

METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma
por: Zhang, Zhijin, et al.
Publicado: (2023)

A cleaved METTL3 potentiates the METTL3–WTAP interaction and breast cancer progression
por: Yan, Chaojun, et al.
Publicado: (2023)

METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability via m6A Modification
por: Zhou, Xinying, et al.
Publicado: (2022)

HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification
por: Yang, Zhi, et al.
Publicado: (2020)

Interactions, localization, and phosphorylation of the m(6)A generating METTL3–METTL14–WTAP complex
por: Schöller, Eva, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_al73jf7qkb1ft21hvd6ajqfcu2